Literature DB >> 24068005

Rifampin heteroresistance in Mycobacterium tuberculosis cultures as detected by phenotypic and genotypic drug susceptibility test methods.

Dorte Bek Folkvardsen1, Vibeke Ø Thomsen, Leen Rigouts, Erik Michael Rasmussen, Didi Bang, Gertjan Bernaerts, Jim Werngren, Juan Carlos Toro, Sven Hoffner, Doris Hillemann, Erik Svensson.   

Abstract

Tuberculosis patients may harbor both drug-susceptible and -resistant bacteria, i.e., heteroresistance. We used mixtures of rifampin-resistant and -susceptible Mycobacterium tuberculosis strains to simulate heteroresistance in patient samples. Molecular tests can be used for earlier discovery of multidrug resistance (MDR), but the sensitivity to detect heteroresistance is unknown. Conventional phenotypic drug susceptibility testing was the most sensitive, whereas two line probe assays and sequencing were unable to detect the clinically important 1% resistant bacteria.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24068005      PMCID: PMC3838044          DOI: 10.1128/JCM.01602-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Heteroresistance in Mycobacterium tuberculosis.

Authors:  H Rinder; K T Mieskes; T Löscher
Journal:  Int J Tuberc Lung Dis       Date:  2001-04       Impact factor: 2.373

2.  Evaluation of mycobacteria growth indicator tube for recovery and drug susceptibility testing of Mycobacterium tuberculosis isolates from respiratory specimens.

Authors:  M Palaci; S Y Ueki; D N Sato; M A Da Silva Telles; M Curcio; E A Silva
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

3.  Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes.

Authors:  G Canetti; W Fox; A Khomenko; H T Mahler; N K Menon; D A Mitchison; N Rist; N A Smelev
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

4.  Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis.

Authors:  H L David
Journal:  Appl Microbiol       Date:  1970-11

5.  Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis.

Authors:  O J Billington; T D McHugh; S H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

6.  Detection of multidrug resistance in Mycobacterium tuberculosis.

Authors:  Jun-ichiro Sekiguchi; Tohru Miyoshi-Akiyama; Ewa Augustynowicz-Kopeć; Zofia Zwolska; Fumiko Kirikae; Emiko Toyota; Intetsu Kobayashi; Koji Morita; Koichiro Kudo; Seiya Kato; Tadatoshi Kuratsuji; Toru Mori; Teruo Kirikae
Journal:  J Clin Microbiol       Date:  2006-11-15       Impact factor: 5.948

7.  MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.

Authors:  G CANETTI; S FROMAN; J GROSSET; P HAUDUROY; M LANGEROVA; H T MAHLER; G MEISSNER; D A MITCHISON; L SULA
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

8.  Characterization of rifampin-resistance in pathogenic mycobacteria.

Authors:  D L Williams; C Waguespack; K Eisenach; J T Crawford; F Portaels; M Salfinger; C M Nolan; C Abe; V Sticht-Groh; T P Gillis
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

9.  Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis.

Authors:  Deneke H Mariam; Yohannes Mengistu; Sven E Hoffner; Dan I Andersson
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

10.  Undetected multidrug-resistant tuberculosis amplified by first-line therapy in mixed infection.

Authors:  Suzanne M Hingley-Wilson; Rosalyn Casey; David Connell; Samuel Bremang; Jason T Evans; Peter M Hawkey; Grace E Smith; Annette Jepson; Stuart Philip; Onn Min Kon; Ajit Lalvani
Journal:  Emerg Infect Dis       Date:  2013-07       Impact factor: 6.883

View more
  35 in total

1.  Impact of gyrB and eis Mutations in Improving Detection of Second-Line-Drug Resistance among Mycobacterium tuberculosis Isolates from Georgia.

Authors:  N Bablishvili; N Tukvadze; E Shashkina; B Mathema; N R Gandhi; H M Blumberg; R R Kempker
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

2.  Non-pncA Gene-Mutated but Pyrazinamide-Resistant Mycobacterium tuberculosis: Why Is That?

Authors:  Jim Werngren; Erik Alm; Mikael Mansjö
Journal:  J Clin Microbiol       Date:  2017-04-12       Impact factor: 5.948

Review 3.  Antimicrobial heteroresistance: an emerging field in need of clarity.

Authors:  Omar M El-Halfawy; Miguel A Valvano
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

4.  Reply to "molecular diagnosis of rifampin-monoresistant tuberculosis in Indian patients: problems with a discordance analysis".

Authors:  Sarman Singh; Syed Beenish Rufai; Parveen Kumar; Jitendra Singh
Journal:  J Clin Microbiol       Date:  2014-09       Impact factor: 5.948

5.  Comparison of different drug susceptibility test methods to detect rifampin heteroresistance in Mycobacterium tuberculosis.

Authors:  Zhijian Zhang; Yufeng Wang; Yu Pang; Changting Liu
Journal:  Antimicrob Agents Chemother       Date:  2014-07-14       Impact factor: 5.191

6.  Rapid detection of isoniazid resistance in Mycobacterium tuberculosis isolates by use of real-time-PCR-based melting curve analysis.

Authors:  Siyu Hu; Guoli Li; Hui Li; Xiaoli Liu; Jianjun Niu; Shengmao Quan; Feng Wang; Huixin Wen; Ye Xu; Qingge Li
Journal:  J Clin Microbiol       Date:  2014-03-05       Impact factor: 5.948

7.  Comparison of Xpert MTB/RIF with line probe assay for detection of rifampin-monoresistant Mycobacterium tuberculosis.

Authors:  Syed Beenish Rufai; Parveen Kumar; Amit Singh; Suneel Prajapati; Veena Balooni; Sarman Singh
Journal:  J Clin Microbiol       Date:  2014-03-19       Impact factor: 5.948

8.  Automated liquid culture system misses isoniazid heteroresistance in Mycobacterium tuberculosis isolates with mutations in the promoter region of the inhA gene.

Authors:  Z Zhang; J Lu; Y Wang; Y Pang; Y Zhao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-10-26       Impact factor: 3.267

9.  Multiplex detection of extensively drug resistant tuberculosis using binary deoxyribozyme sensors.

Authors:  Hillary N Bengtson; Susanne Homolka; Stefan Niemann; Ana Júlia Reis; Pedro Eduardo da Silva; Yulia V Gerasimova; Dmitry M Kolpashchikov; Kyle H Rohde
Journal:  Biosens Bioelectron       Date:  2017-03-01       Impact factor: 10.618

10.  Genomic Analysis of the Evolution of Fluoroquinolone Resistance in Mycobacterium tuberculosis Prior to Tuberculosis Diagnosis.

Authors:  Danfeng Zhang; James E Gomez; Jung-Yien Chien; Nathan Haseley; Christopher A Desjardins; Ashlee M Earl; Po-Ren Hsueh; Deborah T Hung
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.